Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

DERIVATIVE LIABILITIES (Details Narrative)

DERIVATIVE LIABILITIES (Details Narrative)			12 Months Ended
DERIVATIVE LIABILITIES (Details Narrative)	Dec. 23, 2015 USD ($) Investor $ / shares shares	Dec. 22, 2015 USD ($)	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2015 USD ($)	Sep. 21, 2016 USD ($) $ / shares	Sep. 19, 2016 USD ($) $ / shares shares	Sep. 16, 2016 USD ($)	Aug. 16, 2016 USD ($) Investor	Jun. 30, 2016 USD ($)	Sep. 22, 2014 USD ($)
Secured convertible debt				$ 6,000,000	$ 3,000,000
Derivative liability					833,000
Gain (loss) on derivative liabilities				(34,600)
Gains (losses) on extinguishment of debt, total				572,300
Accrued interest				317,000
Note Warrant [Member] \| Ten Accredited Investor [Member]
Derivative liability									$ 1,079,800
Face amount									$ 2,000,000
Number of accredited investors \| Investor									10
Second Amended Note & Warrant Agreement [Member]
Conversion price (in dollars per share) \| $ / shares							$ 5.00
Face amount							$ 6,000,000
Accrued interest							$ 317,000
Second Amended Note & Warrant Agreement [Member] \| Sixteen Accredited Investors [Member]
Secured convertible debt	$ 6,000,000
Number of accredited investors \| Investor	16
Maturity date	Dec. 31, 2017
Second Amended Note & Warrant Agreement [Member] \| 5% Senior Secured Notes Convertible (the "September 2014 Notes") [Member]
Derivative liability		$ 60,200
Gains (losses) on extinguishment of debt, total		$ 772,800
Second Amended Note & Warrant Agreement [Member] \| Secured Convertible Promissory Notes ( December 2015 Notes) [Member]
Conversion price (in dollars per share) \| $ / shares	$ 5.00
Face amount	$ 1,000,000
Accrued interest	$ 317,000
Second Amended Note & Warrant Agreement [Member] \| Warrant [Member]
Conversion price (in dollars per share) \| $ / shares	$ 0.25
Face amount	$ 6,000,000
Second Amended Note & Warrant Agreement [Member] \| Note Warrant [Member]
Conversion price (in dollars per share) \| $ / shares	$ 50.00
Number of shares called \| shares	3,000,000
Second Omnibus Amendment [Member]
Conversion price (in dollars per share) \| $ / shares						$ 5.00	$ 5.00
Face amount							$ 6,000,000
Accrued interest						$ 317,000
Second Omnibus Amendment [Member] \| 5% Senior Secured Notes Convertible (the "September 2014 Notes") [Member]
Conversion price (in dollars per share) \| $ / shares							$ 5.00
Derivative liability			3,412,300					$ 1,070,500
Face amount							$ 6,000,000
Aggregate derivative liability			6,322,000				6,316,965	$ 2,909,700
Accrued interest							$ 316,965
Extinguishment of debt			$ 6,322,000
Number of shares called \| shares							1,263,406
Warrant exercise price (in dollars per share) \| $ / shares							$ 0.05
Original Note Purchase Agreement [Member] \| 5% Senior Secured Notes Convertible (the "September 2014 Notes") [Member]
Secured convertible debt	$ 3,121,900				3,000,000
Derivative liability					833,000
Gain (loss) on derivative liabilities				$ 34,600	$ 162,800
Gains (losses) on extinguishment of debt, total	962,300
Face amount											$ 2,500,000
Aggregate derivative liability	1,022,400									$ 263,100
Accrued interest	$ 121,900